Post by CNBC Africa

South Africa’s High Court has granted Novo Nordisk an interim interdict barring a local pharmacy group from manufacturing and selling compounded weight-loss medicines containing semaglutide, in a ruling that shows tightening scrutiny of unregistered drugs. Read the full article here: https://lnkd.in/dxjwUgbH #CNBCAfrica #DSTV410